Literature DB >> 2031875

Protective effects of propionyl-L-carnitine during ischemia and reperfusion.

A Shug1, D Paulson, R Subramanian, V Regitz.   

Abstract

When cardiac function in isolated rat hearts was impaired by subjecting them to ischemia, subsequent perfusion with propionyl-L-carnitine and related compounds increased their rate of recovery. Thus at 11 mM, both propionyl-L-carnitine and, to a lesser extent, its taurine amide, and also acetyl-L-carnitine, significantly restored cardiac function in 15 minutes after 90 minutes of either low-flow or intermittent no-flow ischemia. Carnitine itself was ineffective. Propionyl-L-carnitine also increased tissue ATP and creatine phosphate compared with controls, but did not affect the levels of long-chain acyl carnitine and coenzyme. These esters also depleted fatty acid peroxidation, as shown with malonaldehyde, and were more effective than carnitine in preventing the production of superoxide. In myocytes, propionyl-L-carnitine alone stimulated palmitate oxidation, but in rat heart homogenates, both L-carnitine and propionyl-L-carnitine did so, while acetyl-L-carnitine was actually inhibitory. Possible mechanisms for the protective action of propionyl-L-carnitine against ischemia include an increased rate of cellular transport, stimulation of fatty acid oxidation, and a reduction of free radical formation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2031875     DOI: 10.1007/bf00128246

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  28 in total

1.  Modulation of adenine nucleotide translocase activity during myocardial ischemia.

Authors:  A L Shug; R Subramanian
Journal:  Z Kardiol       Date:  1987

Review 2.  Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle.

Authors:  J R Neely; H E Morgan
Journal:  Annu Rev Physiol       Date:  1974       Impact factor: 19.318

3.  Microdetermination of (-)carnitine and carnitine acetyltransferase activity.

Authors:  R Parvin; S V Pande
Journal:  Anal Biochem       Date:  1977-05-01       Impact factor: 3.365

4.  Improved pacing tolerance of the ischemic human myocardium after administration of carnitine.

Authors:  J H Thomsen; A L Shug; V U Yap; A K Patel; T J Karras; S L DeFelice
Journal:  Am J Cardiol       Date:  1979-02       Impact factor: 2.778

5.  Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria.

Authors:  J F Turrens; A Alexandre; A L Lehninger
Journal:  Arch Biochem Biophys       Date:  1985-03       Impact factor: 4.013

6.  Cardiovascular and antiarrhythmic effects of carnitine.

Authors:  J R DiPalma; D M Ritchie; R F McMichael
Journal:  Arch Int Pharmacodyn Ther       Date:  1975-10

7.  Characterization of carnitine transport in isolated perfused adult rat hearts.

Authors:  T C Vary; J R Neely
Journal:  Am J Physiol       Date:  1982-04

8.  The efflux of L-carnitine from cells in culture (CCL 27).

Authors:  P Mølstad
Journal:  Biochim Biophys Acta       Date:  1980-03-27

9.  Effects of L-carnitine on exercise tolerance in patients with stable angina pectoris.

Authors:  T Kamikawa; Y Suzuki; A Kobayashi; H Hayashi; Y Masumura; K Nishihara; M Abe; N Yamazaki
Journal:  Jpn Heart J       Date:  1984-07

10.  Protection of the myocardium during ischemic arrest: possible toxicity of carnitine in cardioplegic solutions.

Authors:  D J Hearse; M J Shattock; A S Manning; M V Braimbridge
Journal:  Thorac Cardiovasc Surg       Date:  1980-08       Impact factor: 1.827

View more
  6 in total

1.  L-carnitine reduces malondialdehyde concentrations in isolated rat hearts in dependence on perfusion conditions.

Authors:  H Löster; U Böhm
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

Review 2.  Propionyl-L-carnitine.

Authors:  L R Wiseman; R N Brogden
Journal:  Drugs Aging       Date:  1998-03       Impact factor: 3.923

3.  Differential mechanism of block of palmitoyl lysophosphatidylcholine and of palmitoylcarnitine on inward rectifier K+ channels of guinea-pig ventricular myocytes.

Authors:  T Sato; M Arita; T Kiyosue
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727

4.  L-propionylcarnitine and myocardial performance in stunned porcine myocardium.

Authors:  L M Sassen; D J Duncker; A Hogendoorn; E O McFalls; R Krams; K Bezstarosti; J M Lamers; P D Verdouw
Journal:  Mol Cell Biochem       Date:  1992-10-21       Impact factor: 3.396

5.  Protection of the ischemic diabetic heart by L-propionylcarnitine therapy.

Authors:  D J Paulson; A L Shug; J Zhao
Journal:  Mol Cell Biochem       Date:  1992-10-21       Impact factor: 3.396

6.  Effects of propionyl-L-carnitine on ischemia-reperfusion injury in hamster cheek pouch microcirculation.

Authors:  Dominga Lapi; Lina Sabatino; Giovanna Giuseppina Altobelli; Paolo Mondola; Vincenzo Cimini; Antonio Colantuoni
Journal:  Front Physiol       Date:  2010-10-19       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.